|
| 36493840 | Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): A multicenter open-label randomized controlled trial. | Am Heart J | 2023 |
| 37421271 | Individual Trajectories of Health Status During the First Year of Discharge From Hospitalization for Heart Failure and Their Associations With Death in the Following Years. | J Am Heart Assoc | 2023 |
| 37343143 | A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population. | Eur J Prev Cardiol | 2023 |
| 35295256 | Association of Lean Body Mass and Fat Mass With 1-Year Mortality Among Patients With Heart Failure. | Front Cardiovasc Med | 2022 |
| 35548435 | Systolic Blood Pressure and 1-Year Clinical Outcomes in Patients Hospitalized for Heart Failure. | Front Cardiovasc Med | 2022 |
| 35578345 | Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial. | Trials | 2022 |
| 35534791 | Dose-response association between long-term weight loss in young adults and later-life metabolic health. | Obesity (Silver Spring) | 2022 |
| 35419429 | Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China. | Front Cardiovasc Med | 2022 |
| 35911556 | Impact of Non-cardiac Comorbidities on Long-Term Clinical Outcomes and Health Status After Acute Heart Failure in China. | Front Cardiovasc Med | 2022 |
| 36247443 | Prevalence, treatment, and attributed mortality of elevated blood pressure among a nationwide population-based cohort of stroke survivors in China. | Front Cardiovasc Med | 2022 |
| 35242104 | Association Between Weight Gain From Young to Middle Adulthood and Metabolic Syndrome Across Different BMI Categories at Young Adulthood. | Front Endocrinol (Lausanne) | 2022 |
| 34045213 | Development and validation of a risk prediction model for in-hospital major cardiovascular events in patients hospitalised for acute myocardial infarction. | BMJ Open | 2021 |
| 33799224 | Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study. | Phytomedicine | 2021 |
| 34708035 | Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma. | Front Cell Dev Biol | 2021 |
| 34586366 | Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China. | JAMA Netw Open | 2021 |
| 34732492 | Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. | BMJ Open | 2021 |
| 34374229 | Systolic blood pressure at admission and long-term clinical outcomes in patients hospitalized for heart failure. | ESC Heart Fail | 2021 |
| 34509406 | Health Status Predicts Short- and Long-Term Risk of Composite Clinical Outcomes in Acute Heart Failure. | JACC Heart Fail | 2021 |
| 34107739 | Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014-2018. | Circ Cardiovasc Qual Outcomes | 2021 |
| 33289843 | Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China. | JAMA Netw Open | 2020 |
| 31980439 | Secondary prevention of cardiovascular disease in China. | Heart | 2020 |
| 30998400 | Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial | Circ Cardiovasc Qual Outcomes | 2019 |
| 31474119 | Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial | Circ Cardiovasc Qual Outcomes | 2019 |
| 29102084 | Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). | Lancet | 2017 |
| 27770771 | Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study. | BMC Cardiovasc Disord | 2016 |
| 25713293 | Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study. | J Am Heart Assoc | 2015 |
| 23651962 | [ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2013 |
| 24034088 | National survey of doctor-reported secondary preventive treatment for patients with acute coronary syndrome in China. | Chin Med J (Engl) | 2013 |
| 22800887 | Underuse of statins in patients with atherosclerotic ischemic stroke in China. | Chin Med J (Engl) | 2012 |
| 23253702 | Use of secondary preventive medications in patients with atherosclerotic disease in urban China: a cross-sectional study of 16, 860 patients. | Chin Med J (Engl) | 2012 |